Aleksandar Rajkovic - 17 Feb 2022 Form 4 Insider Report for Bionano Genomics, Inc. (BNGO)

Role
Director
Signature
/s/ R. Erik Holmlin, Attorney-in-fact
Issuer symbol
BNGO
Transactions as of
17 Feb 2022
Net transactions value
$0
Form type
4
Filing time
22 Feb 2022, 17:31:39 UTC
Next filing
13 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BNGO Stock Option (right to buy) Award $0 +194,986 $0.000000 194,986 17 Feb 2022 Common Stock 194,986 $2.04 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares vest in equal monthly installments over a three year period such that the option is fully vested on February 17, 2025, subject to full vesting acceleration upon a change in control (as defined in Bionano Genomic's equity incentive plan).